Okay, let's tackle this question about HHH syndrome. The user wants a detailed explanation for a medical student preparing for exams like NEET PG or USMLE. First, I need to recall what HHH syndrome is. HHH stands for Hyperinsulinism-Hyperammonemia syndrome. Now, I remember that this is a genetic disorder affecting the regulation of insulin.

The key here is the enzyme deficiency. I think it's related to the insulin signaling pathway. The enzyme in question might be glutamate dehydrogenase (GDH), which is involved in the urea cycle and amino acid metabolism. Wait, GDH deficiency can lead to hyperammonemia because it disrupts the conversion of glutamate to alpha-ketoglutarate, affecting the urea cycle. Also, hyperinsulinism occurs because GDH is upregulated by insulin, so a deficiency might lead to uncontrolled insulin release.

Let me double-check. HHH syndrome is indeed caused by mutations in the GLUD1 gene, which encodes GDH. The defective enzyme leads to increased ammonia (hyperammonemia) and excessive insulin production (hyperinsulinism), causing hypoglycemia. The other options are enzymes related to other metabolic disorders. For example, ornithine transcarbamylase deficiency is another urea cycle disorder but presents differently. Pyruvate carboxylase deficiency affects gluconeogenesis, and biotinidase deficiency is a separate metabolic issue. Each of these is a distractor here.

The clinical pearl should highlight the link between GDH deficiency, hyperinsulinism, and hyperammonemia. Students should remember that HHH is a rare cause of neonatal hypoglycemia and that the enzyme is GDH. Also, the treatment might involve avoiding leucine, which is a substrate for GDH. So, the correct answer is Glutamate dehydrogenase (GDH). I need to structure the explanation clearly, making sure each section is concise and covers the necessary points without going over the character limit.

**Core Concept**
HHH syndrome (Hyperinsulinism-Hyperammonemia syndrome) is a rare autosomal dominant disorder caused by mutations in the **GLUD1 gene**, leading to defective **glutamate dehydrogenase (GDH)**. GDH regulates insulin secretion and ammonia metabolism by catalyzing the conversion of glutamate to alpha-ketoglutarate. Its deficiency disrupts the urea cycle and insulin signaling, causing hypoglycemia and hyperammonemia.

**Why the Correct Answer is Right**
Glutamate dehydrogenase (GDH) deficiency impairs the conversion of glutamate to alpha-ketoglutarate, leading to **hyperammonemia** due to urea cycle dysfunction. Simultaneously, GDH deficiency upregulates insulin secretion via the mTOR pathway, causing **hyperinsulinism** and hypoglycemia. This dual mechanism explains the hallmark features of HHH syndrome: neonatal-onset hypoglycemia, elevated ammonia, and elevated glutamine levels in blood.

**Why Each Wrong Option is Incorrect**
**Option A:** Ornithine transcarbamylase deficiency causes hyperammonemia but without hyperinsulinism, and it is X-linked.
**Option B:** Pyruvate carboxylase deficiency leads

✓ Correct Answer: C. Ornithine transcarbomylase